The Asia-Pacific ophthalmic diagnostic devices market was valued at $1,553.80 million in 2019 and is projected to reach $2,182.83 million by 2027, registering a CAGR of 4.3% from 2020 to 2027.

Alexander was previously CEO and co-founder of GLG, a global research platform with offices through the U.S., Europe and Asia. Topography is backed by A16Z and Bain Capital Ventures.